Total amount: € 0,00
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,118
Online ISSN 1827-1634
THE HEART AND ENDOCRINOLOGY
Hyperactivation of the renin-angiotensin-aldosterone system (RAAS), heightened sympathetic drive and uncontrolled synthesis of inflammatory cytokines, exacerbates ventricular contractile dysfunction in heart failure patients. The pathophysiological consequences include excessive fluid retention, increased peripheral vascular resistance, and endothelial dysfunction. Consequently, the demand for additional work by the failing myocardium in the presence of a greater afterload cannot be sustained. Therapeutically exploiting the natriuretic peptide system may represent a physiological approach to dampen the deleterious effects of the neuroendocrine systems and inflammatory cytokines. In both patients and animal models of heart failure, pharmacologically increasing plasma natriuretic peptide levels ameliorated vascular tone, renal and endothelial function, and ventricular contractility. Based on these observations, the following review will highlight the therapeutic benefits of the natriuretic peptide system in heart failure.